Skip to content

Opening book details…

About this Medicine article

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. by Wojtowicz-Praga, S; Torri, J; Johnson, M; Steen, V; Marshall, J; Ness, E; Dickson, R; Sale, M; Rasmussen, H S; Chiodo, T A; Hawkins, M J is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Wojtowicz-Praga, S; Torri, J; Johnson, M; Steen, V; Marshall, J; Ness, E; Dickson, R; Sale, M; Rasmussen, H S; Chiodo, T A; Hawkins, M J
Publisher
American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
Published
1998
Field
Medicine (Health Sciences)

More by Wojtowicz-Praga, S; Torri, J; Johnson, M; Steen, V; Marshall, J; Ness, E; Dickson, R; Sale, M; Rasmussen, H S; Chiodo, T A; Hawkins, M J

Browse all works by Wojtowicz-Praga, S; Torri, J; Johnson, M; Steen, V; Marshall, J; Ness, E; Dickson, R; Sale, M; Rasmussen, H S; Chiodo, T A; Hawkins, M J